Package 43547-331-03

{"route": ["ORAL"], "spl_id": "3e6f512c-8ff3-40b0-bcd3-9bf9bf26a112", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "upc": ["0343547331030", "0343547330033"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310792", "310793"], "spl_set_id": ["72fa8cd4-bc2a-4a7d-8feb-2d60e077d801"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["Solco Healthcare US, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (43547-331-03)", "package_ndc": "43547-331-03", "marketing_start_date": "20140301"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (43547-331-09)", "package_ndc": "43547-331-09", "marketing_start_date": "20140301"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (43547-331-50)", "package_ndc": "43547-331-50", "marketing_start_date": "20140301"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "43547-331_3e6f512c-8ff3-40b0-bcd3-9bf9bf26a112", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "43547-331", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "Solco Healthcare US, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "300 mg/1"}], "application_number": "ANDA203072", "marketing_category": "ANDA", "marketing_start_date": "20140301", "listing_expiration_date": "20271231"}